Jin Li
Shanghai Gobroad Cancer Hospital (China Pharmaceutical University) · Shanghai Goboard Cancer Hospital · Shanghai GoBroad Cancer Hospital China Pharmaceutical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jin Li as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:53 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07514065 · TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary EfficacyTasly Pharmaceutical Group Co., Ltd · recruiting · Metastatic Castration-Resistant Prostate Cancer Patients · principal investigator
- Ph1/Ph2NCT07446725 · A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid TumorsSuzhou Genhouse Bio Co., Ltd. · not yet recruiting · Advanced Solid Tumor Cancer · principal investigator
- Ph1NCT06621615 · Clinical Study of CVL006 Injection in Advanced Solid TumorsConvalife (Shanghai) Co., Ltd. · not yet recruiting · Advanced Solid Tumor · principal investigator
- Ph2NCT06519110 · Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 MutationsConvalife (Shanghai) Co., Ltd. · unknown · Advanced Solid Tumor · principal investigator
- Ph3NCT06351020 · LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma.LaNova Medicines Zhejiang Co., Ltd. · active not recruiting · Locally Advanced or Metastatic GC and GCJ Adenocarcinoma · principal investigator
- Ph1/Ph2NCT06310382 · GH55 for Advanced Cancers With MAPK Mutations: A Study on Safety and Early ResultsSuzhou Genhouse Bio Co., Ltd. · unknown · Advanced Solid Tumors With MAPK Signal Pathway Mutations · principal investigator
- Ph1/Ph2NCT06239155 · A Phase I/II Study of AST-3424 in Subjects With Advanced Solid TumorsAscentawits Pharmaceuticals, Ltd · active not recruiting · Advanced Solid Tumors, Hepatocellular Carcinoma · principal investigator
- Ph1NCT06209385 · A Phase 1 Study of YZJ-5053 Tablets in Participants With Advanced Solid TumorsShanghai Haiyan Pharmaceutical Technology Co., Ltd. · completed · Solid Tumor · principal investigator
- Ph1/Ph2NCT06132932 · A Study of WX390 in Patients With Advanced Solid Tumors With PIK3CA MutationsShanghai Jiatan Pharmatech Co., Ltd · completed · PIK3CA Mutation-Related Tumors · principal investigator
- Ph1NCT06078982 · Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric CancerShanghai East Hospital · unknown · Gastric Cancer, HER2-low-expressing Gastric Cancer · principal investigator
- Ph1NCT06072989 · Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid TumorsShanghai East Hospital · recruiting · Advanced Solid Tumor · principal investigator
- Ph1/Ph2NCT05955105 · A Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesInnolake Biopharm · unknown · Head and Neck Cancer, Cervical Cancer, Endometrial Cancer · principal investigator
- Ph2NCT05934331 · A LM-302 Combination With Other Anti-Tumor Therapies Phase ll StudyLaNova Medicines Zhejiang Co., Ltd. · recruiting · Malignant Neoplasms of Digestive Organs · principal investigator
- Ph3NCT05919381 · Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.Changchun GeneScience Pharmaceutical Co., Ltd. · unknown · Adenocarcinoma of Stomach · principal investigator
- Ph2NCT05799820 · QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanced or Metastatic CRCQilu Pharmaceutical Co., Ltd. · unknown · Colorectal Carcinoma · principal investigator
- Ph1NCT05770310 · A Phase I Study Of JS015 in Patients With Advanced Solid TumorsShanghai Junshi Bioscience Co., Ltd. · completed · Advanced Solid Cancer · principal investigator
- Ph2NCT05678270 · A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic CholangiocarcinomaBeijing InnoCare Pharma Tech Co., Ltd. · recruiting · Intrahepatic Cholangiocarcinoma (ICC) · principal investigator
- Ph1NCT05621486 · A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid TumorsShanghai East Hospital · active not recruiting · Advanced Solid Tumor · principal investigator
- Ph1NCT05554666 · A Study of ASKG315 in Patients With Advanced Solid Tumors.AskGene Pharma, Inc. · unknown · Advanced Solid Tumors · principal investigator
- Ph1NCT05501912 · A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid TumorsABM Therapeutics Shanghai Company Limited · terminated · Advanced Solid Tumor, BRAF V600 Mutation · principal investigator
- Ph1/Ph2NCT05396339 · A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors.SUNHO(China)BioPharmaceutical CO., Ltd. · unknown · Advanced Malignant Solid Tumor · principal investigator
- Ph1/Ph2NCT05396391 · A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant TumorsSUNHO(China)BioPharmaceutical CO., Ltd. · unknown · Advanced Malignant Tumors · principal investigator
- Ph1/Ph2NCT05338957 · A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.Shanghai Miracogen Inc. · unknown · Advanced Malignant Solid Tumors · principal investigator
- Ph1NCT05327231 · IN10018 Monotherapy or in Combination With Docetaxel in Gastric or GEJ AdenocarcinomaInxMed (Shanghai) Co., Ltd. · completed · Gastric Cancer · principal investigator
- Ph1NCT05278546 · A Study of ILB2109 in Patients With Advanced Solid MalignanciesInnolake Biopharm · active not recruiting · Advanced Solid Tumor · principal investigator
- Ph1/Ph2NCT05161390 · Study of LM-302 in Patients With Advance Solid TumorsLaNova Medicines Zhejiang Co., Ltd. · completed · Advanced Solid Tumor · principal investigator
- Ph2NCT05141747 · A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.Shanghai Miracogen Inc. · unknown · Locally Advanced Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer · principal investigator
- Early Ph1NCT05137275 · Study of Anti-5T4 CAR-raNK Cell Therapy in Locally Advanced or Metastatic Solid TumorsShanghai East Hospital · unknown · Locally Advanced or Metastatic Solid Tumors · principal investigator
- Ph1NCT05116709 · Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid TumorsBio-Thera Solutions · completed · Locally Advanced or Metastatic Solid Tumors · principal investigator
- Ph1/Ph2NCT05107011 · Phase I/II Clinical Trial of LBL-015 for InjectionNanjing Leads Biolabs Co.,Ltd · completed · Advanced Malignant Tumor · principal investigator
- Ph1NCT05051241 · A Study of GFH018 in Patients With Advanced Solid TumorsZhejiang Genfleet Therapeutics Co., Ltd. · completed · Advanced Solid Tumor · principal investigator
- Ph1NCT04947033 · A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid TumorsI-Mab Biopharma US Limited · unknown · Advanced Solid Tumor · principal investigator
- Ph1NCT04941339 · A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid TumorsShanghai Miracogen Inc. · unknown · Advanced Solid Tumor · principal investigator
- Ph3NCT04914598 · A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural EffusionsJiangsu Simcere Pharmaceutical Co., Ltd. · active not recruiting · Malignant Pleural Effusion · study chair
- Ph2NCT04911907 · Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid TumorsBeijing Biostar Pharmaceuticals Co., Ltd. · completed · Solid Tumor · principal investigator
- Ph1NCT04802980 · A Study of HB002.1T Plus Chemotherapy in Subjects With Solid TumorHuabo Biopharm Co., Ltd. · unknown · Solid Tumor · principal investigator
- Ph4NCT04767724 · Extracorporeal Shock Wave Versus Local Corticosteroid Injection for Carpal Tunnel SyndromeChinese Medical Association · completed · Carpal Tunnel Syndrome, Shock Wave · study chair
- Ph1NCT04758897 · Clinical Study of VG161 in Subjects With Advanced Malignant Solid TumorsCNBG-Virogin Biotech (Shanghai) Ltd. · unknown · Advanced Malignant Solid Tumor · principal investigator
- Ph1NCT04630522 · Efficacy and Safety of JMT103 in Patients With Bone Metastases From Solid TumorsShanghai JMT-Bio Inc. · completed · Bone Metastases From Solid Tumors · principal investigator
- Ph1/Ph2NCT04571892 · A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid TumorsShanghai East Hospital · unknown · Malignant Solid Tumor · principal investigator
- Ph1NCT04467853 · A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid TumorsShanghai East Hospital · terminated · Solid Tumors, Adult · principal investigator
- Ph1NCT04423380 · A Study to Investigate Safety and Tolerability of SH3051 Capsule in Patients With Advanced Solid TumorsNanjing Sanhome Pharmaceutical, Co., Ltd. · unknown · Advanced Solid Tumor · principal investigator
- Ph1NCT04400383 · Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid TumorsCARsgen Therapeutics Co., Ltd. · completed · Solid Tumor, Gastric Cancer, Pancreatic Adenocarcinoma · principal investigator
- Ph1/Ph2NCT04198480 · A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCMShanghai JMT-Bio Inc. · terminated · Hypercalcemia of Malignancy · principal investigator
- Ph1/Ph2NCT03903705 · : A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid TumorsHutchmed · completed · Advanced Solid Tumor · principal investigator
- Ph1NCT03852823 · Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced TumoursCSPC ZhongQi Pharmaceutical Technology Co., Ltd. · unknown · Advanced Solid Tumours, Cervical Cancer, Malignant Mesothelioma · principal investigator
- Ph2NCT03817411 · Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ CancerTaizhou EOC Pharma Co., Ltd. · unknown · Gastric Cancer · study chair
- Ph1NCT03792958 · Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid TumorsAnewPharma · unknown · Advanced Malignant Solid Tumors · principal investigator
- Ph1/Ph2NCT03758664 · Clinical Study of ICP-192 in Solid Tumors PatientsBeijing InnoCare Pharma Tech Co., Ltd. · unknown · Solid Tumor · principal investigator
- Ph1NCT03730142 · A Study of WXFL10030390 in Patients With Advanced Solid Tumors or LymphomaShanghai Jiatan Pharmatech Co., Ltd · completed · Advanced Cancer · principal investigator
- Ph1NCT03642834 · Study of ICP-105 in Solid Tumors PatientsBeijing InnoCare Pharma Tech Co., Ltd. · completed · Solid Tumor · principal investigator
- Ph1NCT03618043 · Safety and Tolerability of SH-1028 in Patients With Advanced Solid CancerNanjing Sanhome Pharmaceutical, Co., Ltd. · unknown · Advanced Solid Cancer · principal investigator
- Ph1NCT03607188 · Study of Alkotinib in Patients With Advanced Non Small Cell Lung CancerSuzhou Zelgen Biopharmaceuticals Co.,Ltd · completed · Non-small Cell Lung Cancer · principal investigator
- Ph1NCT03550508 · Safety, Tolerability and PK/PD of JMT103 in Patients With Bone Metastases From TumorsShanghai JMT-Bio Inc. · unknown · Bone Metastases · principal investigator
- Ph1/Ph2NCT03439761 · An Open-label Phase I/II Clinical Trial of PT-112 Injection for Advanced Solid Tumors and Advanced Hepatocellular CarcinomaSciClone Pharmaceuticals · unknown · Advanced Solid Tumors · principal investigator
- Ph1NCT03313219 · Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in ChinaChangchun GeneScience Pharmaceutical Co., Ltd. · unknown · Solid Tumor · principal investigator
- Ph1NCT03117101 · Study of the AL3810 in the Treatment of Advanced Solid TumorHaihe Biopharma Co., Ltd. · completed · Advanced Solid Tumors · principal investigator
- Ph2NCT02521441 · A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.EVIVE Biotechnology · completed · Neutropenia · principal investigator
- N/ANCT02520570 · Post-market Safety Reassessment of Ulinastatin for InjectionTechpool Bio-Pharma Co., Ltd. · unknown · Adverse Reaction to Drug · principal investigator
- Ph1NCT02453464 · A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal CancerJiangsu Simcere Pharmaceutical Co., Ltd. · unknown · Metastatic Colorectal Cancer · principal investigator
- Ph4NCT02426034 · A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric CancerJiangsu HengRui Medicine Co., Ltd. · completed · Advanced Gastric or Gastroesophageal Junction Adenocarcinoma · principal investigator
- Ph3NCT02395016 · A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic CancerBiotech Pharmaceutical Co., Ltd. · completed · Pancreatic Cancer · principal investigator
- Ph3NCT02314819 · A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients (FRESCO)Hutchison Medipharma Limited · completed · Colorectal Cancer · principal investigator
- Ph1NCT02252913 · A Study of Safety and Pharmacokinetics of Volitinib With Docetaxel in Patients With Advanced Gastric CancerHutchison Medipharma Limited · completed · Gastric Cancer · principal investigator
- Ph2NCT02196688 · Study of Fruquintinib in Patients With Metastatic Colorectal CancerHutchison Medipharma Limited · completed · Colorectal Cancer · principal investigator
- Ph2NCT01963702 · A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGCFudan University · unknown · Gastric Cancer · principal investigator
- Ph1NCT01935453 · A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat CancerOrienGene Biotechnology Ltd. · completed · Melanoma, Liver Cancer, Pancreatic Cancer · principal investigator
- Ph1NCT01847118 · A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid TumorsJiangsu Simcere Pharmaceutical Co., Ltd. · unknown · Advanced Solid Tumors, Metastatic Solid Tumors · principal investigator
- Ph2NCT01531777 · Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal CancerJiangsu HengRui Medicine Co., Ltd. · completed · Colorectal Cancer · principal investigator
- Ph3NCT01512745 · Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric CancerJiangsu HengRui Medicine Co., Ltd. · completed · Advanced or Metastatic Gastric Cancer · principal investigator
- Ph1NCT01416623 · A Phase I Study of Henatinib in Patients With Advanced Solid MalignanciesJiangsu HengRui Medicine Co., Ltd. · terminated · Advanced Solid Cancer · principal investigator
- Ph2NCT01322152 · Study of Irinotecan Plus Capecitabine to Treat Advanced Colorectal CancerFudan University · completed · Colorectal Cancer · principal investigator
- Ph1NCT01310478 · Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal CancerFudan University · unknown · Colorectal Neoplasm · principal investigator
- Ph2NCT01193452 · S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal CancerFudan University · unknown · Colorectal Cancer · principal investigator
- Ph2NCT00992199 · Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric CancerFudan University · unknown · Advanced Gastric Cancer · principal investigator
- Ph2/Ph3NCT00970138 · Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric CancerFudan University · completed · Gastric Carcinoma · principal investigator
- Ph1NCT00881816 · Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric CarcinomaNanjing Sike Pharmaceutical Co., Ltd. · unknown · Advanced Gastric Carcinoma · principal investigator
- Ph1NCT00881101 · Clinical Study of Liposomal Paclitaxel in Chinese PatientsNanjing Sike Pharmaceutical Co., Ltd. · unknown · Solid Tumor · principal investigator
- Ph2NCT00839111 · Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin TreatmentFudan University · unknown · Colorectal Neoplasms · principal investigator
- Ph2NCT00699881 · Study of Cetuximab to Treat Gastric CancerFudan University · completed · Gastric Cancer · principal investigator
- Ph1NCT00633490 · Study of Apatinib as an Inhibitor of Tumor AngiogenesisFudan University · unknown · Tumor · principal investigator
- Ph3NCT00615667 · Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)Sun Yat-sen University · completed · Kidney Diseases, Nephrotic Syndrome, Tacrolimus · principal investigator
- Ph3NCT00615173 · Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus NephritisSun Yat-sen University · completed · Kidney Diseases, Lupus Nephritis, Tacrolimus · principal investigator
- Ph4NCT00606515 · Pharmacokinetics Study of Liposomal Paclitaxel in HumansShandong Luye Pharmaceutical Co., Ltd. · completed · Cancer · principal investigator
- Ph2NCT00595985 · Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric CancerFudan University · terminated · Gastric Cancer · principal investigator
- Ph2NCT00595972 · Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric CancerFudan University · completed · Gastric Cancer · principal investigator
- Ph2NCT00568971 · Study of Weekly DCF to Treat Advanced Gastric CancerFudan University · terminated · Gastric Cancer · principal investigator
- Ph2NCT00568529 · Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric CancerFudan University · suspended · Gastric Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 109 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Development of nucleic acid delivery platform based on polymeric CXCR4 antagonistsR41TR001312 · NCATS · BOHEMICA PHARMACEUTICALS, LLC · fiscal years 2016 · $347,546 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:53 UTC. The ranking covers the 200 most relevant of 5085 PubMed records, and a shared surname and initials can bring in a namesake. All 5085 on PubMed
- Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer.N Engl J Med · 202582 citationsRCR 16.4
- 47 citationsRCR 7.3
- A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus.N Engl J Med · 202545 citationsRCR 11.9
- 30 citationsRCR 7.0
- 28 citationsRCR 14.0
- 26 citationsRCR 13.0
- Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer.N Engl J Med · 202525 citationsRCR 6.5
- 23 citationsRCR 5.7
- 21 citationsRCR 3.7
- Long-Term Outcomes of Left Bundle-Branch Pacing vs Biventricular Pacing in Heart Failure: The HeartSync-LBBP Randomized Clinical Trial.JAMA Cardiol · 202621 citationsRCR 10.5